ATF7 and neoplasm: We also believe that in order to increase the repertoire of potent and safe TRAIL-based anti-tumor agents it would be beneficial to analyze in vivo other fully human leucine-zipper-TRAIL fusion proteins with activity and stability comparable to those of ATF7-TRAIL (Tables 2 and 3).